|Articles|January 29, 2020
Thorough and Reproducible Analytical Characterization of an Innovator and Biosimilar Pair
Author(s)Agilent Technologies
• Solutions for comparing innovator and biosimilar mAbs • Biosimilar case studies
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
